Biologic Drugs

Dec 05, 2018
By Pharmaceutical Technology Editors
GSK and TESARO have entered into a definitive agreement concerning GSK's acquisition of TESARO for an aggregate cash consideration worth approximately $5.1 billion.
Dec 02, 2018
Pharmaceutical Technology
Antibody-based drugs offer new mechanisms of action and greater specificity.
Dec 01, 2018
Unprocessed bulk material harvested directly from the bioreactor should be tested for contamination prior to downstream processing.
Nov 29, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
The partnership, co-funded by Enterprise Ireland, will develop technologies for monitoring the quality of biopharma processes.
Nov 16, 2018
Moving forward with gene therapy development requires a “quantum leap” in manufacturing capabilities.
Nov 15, 2018
Pharmaceutical Technology
The testing of raw materials is essential as raw material quality determines the outcome of biologic product quality.
Nov 09, 2018
By Pharmaceutical Technology Editors
The new program will provide cell and gene therapy companies a more efficient way to ensure quality compliance across collection center networks and to minimize quality system audit burden on these centers.
Nov 02, 2018
Pharmaceutical Technology
As biologic drugs grow increasingly complex, drug delivery mechanisms such as prefilled syringes are being adapted to meet the challenges.
Nov 02, 2018
By Pharmaceutical Technology Editors
The company received FDA approval for Hyrimoz (adalimumab-adaz), its biosimilar referencing AbbVie’s blockbuster Humira (adalimumab).
Oct 30, 2018
By Pharmaceutical Technology Editors
Mylan announced the launch of its biosimilar to AbbVie’s Humira across major European markets.
native1_300x100
lorem ipsum